| Dir : /home/ithome/mail/new/ |
| Server: Linux host100322.itwesthosting.com 3.10.0-1160.144.1.el7.tuxcare.els4.x86_64 #1 SMP Tue Apr 7 08:40:40 UTC 2026 x86_64 IP: 144.91.64.173 |
| Dir : /home/ithome/mail/new/1774056973.M584852P25850.host100322.itwesthosting.com,S=28768,W=29165 |
Return-Path: <harper.anderson@ajomaa.org>
Delivered-To: ithome@host100322.itwesthosting.com
Received: from host100322.itwesthosting.com
by host100322.itwesthosting.com with LMTP
id 3A9sIg32vWn6ZAAAp0YrwQ
(envelope-from <harper.anderson@ajomaa.org>)
for <ithome@host100322.itwesthosting.com>; Sat, 21 Mar 2026 02:36:13 +0100
Return-path: <harper.anderson@ajomaa.org>
Envelope-to: ljerka.pavkovic@bolnica-lipik.hr
Delivery-date: Sat, 21 Mar 2026 02:36:13 +0100
Received: from static27-14.uszonea.dm.aliyun.com ([8.221.27.14]:35593)
by host100322.itwesthosting.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
(Exim 4.96.2)
(envelope-from <harper.anderson@ajomaa.org>)
id 1w3lGA-0006ij-1c
for ljerka.pavkovic@bolnica-lipik.hr;
Sat, 21 Mar 2026 02:36:13 +0100
X-AliDM-RcptTo: bGplcmthLnBhdmtvdmljQGJvbG5pY2EtbGlwaWsuaHI=
Feedback-ID: default:harper.anderson@ajomaa.org:alibabak_SmtpBatch:185331
DKIM-Signature:v=1; a=rsa-sha256; c=relaxed/relaxed;
d=ajomaa.org; s=aliyun-us-east-1;
t=1774056970; h=Date:From:To:Message-ID:Subject:MIME-Version:Content-Type;
bh=ClRyraU5NYQV1RFEWO5Xaj56jHwhiT2f66BknpODo6w=;
b=npQQ/3+V+bvAzZtGmzkPlpGEHefa+ZC1Zid3CM+OL9hTyf9uBhaa3PbZa1TvOQTa9DaTcVZzJYyCHyKPyMvBY09n0YqFZy+rWnpYM0E2UqIGC9FacNX6lX3AsNw/sWKdD4Be9TAnUXlwzya/jMTOpE74tbV2IKFIN5aNHBrJRvE=
Received: from iZmfui09d3qolaZ(mailfrom:Harper.Anderson@ajomaa.org fp:SMTPD_.XusbmZ0h.t cluster:dm-ay35u-a)
by smtp.aliyun-inc.com(127.0.0.1);
Sat, 21 Mar 2026 09:36:09 +0800
X-EnvId: 1800000026060705914
Date: Sat, 21 Mar 2026 09:36:09 +0800 (CST)
From: Harper Anderson <Harper.Anderson@ajomaa.org>
Reply-To: Harper.Anderson@ajomie.org
To: ljerka.pavkovic@bolnica-lipik.hr
Message-ID: <0325f76d-8547-4f53-b3e3-47d19debb715@ajomaa.org>
Subject: Dear Ninoslav Mimica: Invite You to Join the Editorial Board of
Chemical and Biomolecular Engineering
MIME-Version: 1.0
Content-Type: text/html;charset=UTF-8
Content-Transfer-Encoding: quoted-printable
X-AliDM-Settings: eyJWZXJzaW9uIjoiMS4wIiwiVW5zdWJzY3JpYmUiOnsiRmlsdGVyTGV2ZWwiOiJtYWlsZnJvbV9kb21haW4iLCJMaW5rVHlwZSI6ImRlZmF1bHQifX0=
X-Spam-Status: No, score=4.9
X-Spam-Score: 49
X-Spam-Bar: ++++
X-Ham-Report: Spam detection software, running on the system "host100322.itwesthosting.com",
has NOT identified this incoming email as spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: Call for Editorial Committee Member/Reviewer Collaborate
with Your Peers Improve Your Academic Reputation Assessing the Latest Research
Dear Ninoslav Mimica, Reach a global audience with your researc [...]
Content analysis details: (4.9 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
5.0 URIBL_BLACK Contains an URL listed in the URIBL blacklist
[URIs: ajomaa.org]
0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[8.221.27.14 listed in bl.score.senderscore.com]
0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE:
The query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[8.221.27.14 listed in sa-accredit.habeas.com]
-0.0 SPF_PASS SPF: sender matches SPF record
0.0 HTML_FONT_LOW_CONTRAST BODY: HTML font color similar or
identical to background
0.1 MIME_HTML_ONLY BODY: Message only has text/html MIME parts
0.0 HTML_MESSAGE BODY: HTML included in message
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
-0.1 DKIM_VALID_EF Message has a valid DKIM or DK signature from
envelope-from domain
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from
author's domain
0.0 UNPARSEABLE_RELAY Informational: message has unparseable relay
lines
X-Spam-Flag: NO
X-From-Rewrite: unmodified, forwarded message
<br/><br/><meta charset=3D'utf-8' /><html lang=3D"en"> <body> <table style=
=3D"background:#eeecee;color:#222222;padding:27px 27px;display:block; width=
:100%;"> =09 =09<tr><td style=3D"padding:0px;"> =09=09<table cellspacing=3D=
"0" cellpadding=3D"0" border=3D"0" width=3D"780" style=3D"border:0;border-s=
pacing:0;"> =09=09=09<tr><td style=3D"padding:0px;"> =09=09=09=09<table cel=
lspacing=3D"0" cellpadding=3D"0" border=3D"0" width=3D"100%" style=3D"borde=
r:0;border-spacing:0;"> =09=09=09=09=09<tr><td style=3D"width: 740px; backg=
round:#fffcf0;"> =09=09=09=09=09=09<table cellspacing=3D"0" cellpadding=3D"=
0" border=3D"0" width=3D"100%" style=3D"border:0;border-spacing:0;border-co=
llapse:collapse;"> =09=09=09=09=09=09=09<tr><td style=3D"background:#df8334=
; border-top:8px solid #fffcf0;"> =09=09=09=09=09=09=09=09<table cellspacin=
g=3D"0" cellpadding=3D"0" border=3D"0" width=3D"100%" style=3D"border:0;bor=
der-spacing:0;border-collapse:collapse;"> =09=09=09=09=09=09=09=09=09<tr><t=
d style=3D"line-height: 24px;width: 800px;vertical-align: middle;text-align=
: left;font-weight: bold;"><table cellspacing=3D"0" cellpadding=3D"0" borde=
r=3D"0" width=3D"100%" style=3D"border:0;border-spacing:0;border-collapse:c=
ollapse;"><tr><td style=3D"padding:20px 20px;font-size: 22px; color:#fffcff=
; line-height:24px; ;font-weight: bold;text-align:left;"><font face=3D"Time=
s New Roman">Call for Editorial Committee Member/Reviewer</font></td></tr><=
tr><td style=3D"display:inline-block; padding-left:20px;"> =09=09=09=09=09=
=09=09=09=09=09=09=09<table cellspacing=3D"0" cellpadding=3D"0" border=3D"0=
" width=3D"100%" style=3D"border:0;border-spacing:0;border-collapse:collaps=
e;;text-align:left;"> =09=09=09=09=09=09=09=09=09=09=09=09=09<tr><td style=
=3D"display:inline-block; background:#ffe3cb; padding:2px 6px; line-height:=
24px; border-radius:4px; font-size: 13px;font-family: Tahoma, Arial, Helvet=
ica, sans-serif;">Collaborate with Your Peers</td> =09=09=09=09=09=09=09=09=
=09=09=09=09=09<td style=3D"width:4px; display:inline-block;"></td> =09=09=
=09=09=09=09=09=09=09=09=09=09=09<td style=3D"display:inline-block; backgro=
und:#ffe3cb; padding:2px 6px; line-height:24px; border-radius:4px; font-siz=
e: 13px;font-family: Tahoma, Arial, Helvetica, sans-serif;">Improve Your Ac=
ademic Reputation</td> =09=09=09=09=09=09=09=09=09=09=09=09=09<td style=3D"=
width:4px; display:inline-block;"></td> =09=09=09=09=09=09=09=09=09=09=09=
=09=09<td style=3D"display:inline-block; background:#ffe3cb; padding:2px 6p=
x; line-height:24px; border-radius:4px; font-size: 13px;font-family: Tahoma=
, Arial, Helvetica, sans-serif;">Assessing the Latest Research</td></tr> =
=09=09=09=09=09=09=09=09=09=09=09=09</table> =09=09=09=09=09=09=09=09=09=09=
=09</td></tr></table></td><td style=3D"vertical-align: middle;width: 80px;"=
> <table cellspacing=3D"0" cellpadding=3D"0" border=3D"0" w=
idth=3D"100%" style=3D"border:0;border-spacing:0;border-collapse:collapse;"=
><tr><td><a href=3D"http://www.chembiomoleng.com/lg49/intro/wsabxr" target=
=3D"_blank" style=3D"display: inline-block;text-decoration: none;font-size:=
0;"> <table cellspacing=3D"0" cellpadding=3D"0" border=3D"0" width=3D"=
100%" style=3D"border:0;border-spacing:0;border-collapse:collapse;"><tr><td=
style=3D"width: 60px;height: 30px;background: #FD0104;text-align: right;bo=
rder-top-left-radius: 50% 100%;border-top-right-radius: 50% 100%;"> =
<table cellspacing=3D"0" cellpadding=3D"0" border=3D"0" width=3D"100%" sty=
le=3D"border:0;border-spacing:0;border-collapse:collapse;"><tr><td style=3D=
"height: 5px;"></td></tr></table> <table cellspacing=3D"0" cellpadd=
ing=3D"0" border=3D"0" style=3D"border:0;border-spacing:0;border-collapse:c=
ollapse;display: inline-block;"><tr><td style=3D"display: inline-block;widt=
h: 50px;height: 25px;background: #F6EC06;text-align: left;border-top-left-r=
adius: 50% 100%;border-top-right-radius: 50% 100%;"> <table cel=
lspacing=3D"0" cellpadding=3D"0" border=3D"0" width=3D"100%" style=3D"borde=
r:0;border-spacing:0;border-collapse:collapse;"><tr><td style=3D"height: 5p=
x;"></td></tr></table> <table cellspacing=3D"0" cellpadding=3D"=
0" border=3D"0" width=3D"100%" style=3D"border:0;border-spacing:0;border-co=
llapse:collapse;"><tr><td style=3D"display: inline-block;width: 40px;height=
: 20px;background: #FD0104;text-align: right;border-top-left-radius: 50% 10=
0%;border-top-right-radius: 50% 100%;"> <table cellspacing=
=3D"0" cellpadding=3D"0" border=3D"0" width=3D"100%" style=3D"border:0;bord=
er-spacing:0;border-collapse:collapse;"><tr><td style=3D"height: 5px;"></td=
></tr></table> <table cellspacing=3D"0" cellpadding=3D"0" b=
order=3D"0" style=3D"border:0;border-spacing:0;border-collapse:collapse;dis=
play: inline-block;"><tr><td style=3D"display: inline-block;width: 30px;hei=
ght: 15px;background: #F6EC06;text-align: left;border-top-left-radius: 50% =
100%;border-top-right-radius: 50% 100%;"> <table cellsp=
acing=3D"0" cellpadding=3D"0" border=3D"0" width=3D"100%" style=3D"border:0=
;border-spacing:0;border-collapse:collapse;"><tr><td style=3D"height: 5px;"=
></td></tr></table> <table cellspacing=3D"0" cellpaddin=
g=3D"0" border=3D"0" width=3D"100%" style=3D"border:0;border-spacing:0;bord=
er-collapse:collapse;"><tr><td style=3D"display: inline-block;width: 20px;h=
eight: 10px;background: #00719C;border-top-left-radius: 50% 100%;border-top=
-right-radius: 50% 100%;"></td></tr></table> </td></tr></ta=
ble> </td></tr></table> </td></tr></table> </td></t=
r></table> <table cellspacing=3D"0" cellpadding=3D"0" border=3D"0" widt=
h=3D"100%" style=3D"border:0;border-spacing:0;border-collapse:collapse;"><t=
r><td style=3D"width: 60px;height: 30px;background: #FD0104;text-align: lef=
t;border-bottom-left-radius: 50% 100%;border-bottom-right-radius: 50% 100%;=
"> <table cellspacing=3D"0" cellpadding=3D"0" border=3D"0" width=3D=
"100%" style=3D"border:0;border-spacing:0;border-collapse:collapse;"><tr><t=
d style=3D"display: inline-block;width: 50px;height: 25px;background: #F6EC=
06;text-align: right;border-bottom-left-radius: 50% 100%;border-bottom-righ=
t-radius: 50% 100%;"> <table cellspacing=3D"0" cellpadding=3D"0=
" border=3D"0" style=3D"border:0;border-spacing:0;border-collapse:collapse;=
display: inline-block;"><tr><td style=3D"display: inline-block;width: 40px;=
height: 20px;background: #FD0104;text-align: left;border-bottom-left-radius=
: 50% 100%;border-bottom-right-radius: 50% 100%;"> <table c=
ellspacing=3D"0" cellpadding=3D"0" border=3D"0" width=3D"100%" style=3D"bor=
der:0;border-spacing:0;border-collapse:collapse;"><tr><td style=3D"display:=
inline-block;width: 30px;height: 15px;background: #F6EC06;text-align: righ=
t;border-bottom-left-radius: 50% 100%;border-bottom-right-radius: 50% 100%;=
"> <table cellspacing=3D"0" cellpadding=3D"0" border=3D=
"0" style=3D"border:0;border-spacing:0;border-collapse:collapse;display: in=
line-block;"><tr><td style=3D"display: inline-block;width: 20px;height: 10p=
x;background: #00719C;border-bottom-left-radius: 50% 100%;border-bottom-rig=
ht-radius: 50% 100%;"></td></tr></table> <table cellspa=
cing=3D"0" cellpadding=3D"0" border=3D"0" width=3D"100%" style=3D"border:0;=
border-spacing:0;border-collapse:collapse;"><tr><td style=3D"height: 5px;">=
</td></tr></table> </td></tr></table> <tabl=
e cellspacing=3D"0" cellpadding=3D"0" border=3D"0" width=3D"100%" style=3D"=
border:0;border-spacing:0;border-collapse:collapse;"><tr><td style=3D"heigh=
t: 5px;"></td></tr></table> </td></tr></table> <tab=
le cellspacing=3D"0" cellpadding=3D"0" border=3D"0" width=3D"100%" style=3D=
"border:0;border-spacing:0;border-collapse:collapse;"><tr><td style=3D"heig=
ht: 5px;"></td></tr></table> </td></tr></table> <table cell=
spacing=3D"0" cellpadding=3D"0" border=3D"0" width=3D"100%" style=3D"border=
:0;border-spacing:0;border-collapse:collapse;"><tr><td style=3D"height: 5px=
;"></td></tr></table> </td></tr></table> </a></td></tr></table> =
</td></tr> =09=09=09=09=09=09=09=09=09<tr><td style=3D"padding-bottom:=
16px;" colspan=3D"2"> =09=09=09=09=09=09=09=09=09=09<table cellspacing=3D"0=
" cellpadding=3D"0" border=3D"0" width=3D"100%" style=3D"border:0;border-sp=
acing:0;border-collapse:collapse;;text-align:left;"> =09=09=09=09=09=09=09=
=09=09=09=09<tr><td style=3D"padding:20px;"> =09=09=09=09=09=09=09=09=09=09=
=09=09<table cellspacing=3D"0" cellpadding=3D"0" border=3D"0" width=3D"100%=
" style=3D"border:0;border-spacing:0;border-collapse:collapse;"> =09=09=09=
=09=09=09=09=09=09=09=09=09=09<tr><td style=3D"padding:0px;"> =09=09=09=09=
=09=09=09=09=09=09=09=09=09=09<table cellspacing=3D"0" cellpadding=3D"0" bo=
rder=3D"0" width=3D"100%" style=3D"border:0;border-spacing:0;border-collaps=
e:collapse;"> =09=09=09=09=09=09=09=09=09=09=09=09=09=09<tr><td style=3D"ba=
ckground:#fffcff; border:1px solid #f0d3ba; padding:16px;"> =09=09=09=09=09=
=09=09=09=09=09=09=09=09=09=09<table cellspacing=3D"0" cellpadding=3D"0" bo=
rder=3D"0" width=3D"100%" style=3D"border:0;border-spacing:0;"> =09=09=09=
=09=09=09=09=09=09=09=09=09=09=09=09<tr><td style=3D"padding: 0px;font-fami=
ly: Tahoma, Arial, Helvetica, sans-serif; font-size: 14px; line-height: 24p=
x; text-align: left;">Dear Ninoslav Mimica,</td></tr> =09=09=09=09=09=09=09=
=09=09=09=09=09=09=09=09<tr><td style=3D"padding: 10px 0;font-family: Taho=
ma, Arial, Helvetica, sans-serif; font-size: 14px; line-height: 24px; text-=
align: left;">Reach a global audience with your research through this platf=
orm's <span style=3D"font-weight: bold;">300+ open-access journals</span>, =
which cover an extensive range of disciplines. For the last <span style=3D"=
font-weight: bold;">ten years</span>, more than 180 journals have seen unin=
terrupted publication.</td></tr><tr><td style=3D"padding: 0px 0px 20px;font=
-family: Tahoma, Arial, Helvetica, sans-serif; font-size: 14px; line-height=
: 24px; text-align: left;"><span style=3D"font-style:italic;color:#f14310;f=
ont-weight:bold;">Chemical and Biomolecular Engineering</span> (e-ISSN: 257=
8-8884), is a global journal published on this platform, covering a wide ar=
ray of subjects within chemical and biomolecular engineering.</td></tr> =09=
=09=09=09=09=09=09=09=09=09=09=09=09=09=09<tr><td style=3D"font-size: 16px;=
color: #c86611; font-weight: bold; text-align: center; padding: 12px 0;bac=
kground:#ffe3cb;font-family: Tahoma, Arial, Helvetica, sans-serif; line-hei=
ght: 24px; ">Join as Editorial Board Members/Reviewers</td></tr> =09=09=09=
=09=09=09=09=09=09=09=09=09=09=09=09<tr><td style=3D"padding-top:10px;font-=
family: Tahoma, Arial, Helvetica, sans-serif; font-size: 14px; line-height:=
24px; text-align: left;">Your research paper <span style=3D"font-style:ita=
lic;">"Alzheimerova bolest - izazov dana=C5=A1njice"</span> has left a deep=
impression on us, so we=E2=80=99d like to invite you to apply for the memb=
ership on our Editorial Board or Reviewer Team. It is believed that if you =
could become one of our members, you would make a difference in maintaining=
the quality and ranking of the journal.</td></tr> =09=09=09=09=09=09=09=09=
=09=09=09=09=09=09=09<tr><td style=3D"padding-top:10px;font-family: Tahoma,=
Arial, Helvetica, sans-serif; font-size: 14px; line-height: 24px; text-ali=
gn: left;">By the link below, you can get more details to join the Reviewer=
Team/Editorial Board:</td></tr> =09=09=09=09=09=09=09=09=09=09=09=09=09=09=
=09<tr><td style=3D"padding:0px;"> =09=09=09=09=09=09=09=09=09=09=09=09=09=
=09=09<a href=3D"http://www.chembiomoleng.com/jy/wsabxr" border=3D"0" targe=
t=3D"_blank" style=3D"text-decoration:none;font-size: 14px;color:#0000ff;wh=
ite-space:nowrap; font-weight:bold;font-family: Tahoma, Arial, Helvetica, s=
ans-serif;">http://www.chembiomoleng.com/jy/wsabxr</a> =09=09=09=09=09=09=
=09=09=09=09=09=09=09=09=09</td></tr> =09=09=09=09=09=09=09=09=09=09=09=09=
=09=09=09</table> =09=09=09=09=09=09=09=09=09=09=09=09=09=09</td></tr> =09=
=09=09=09=09=09=09=09=09=09=09=09=09=09</table> =09=09=09=09=09=09=09=09=09=
=09=09=09=09</td></tr> =09=09=09=09=09=09=09=09=09=09=09=09=09<tr><td style=
=3D"height:10px;line-height:10px;font-size:0;"> </td></tr> =09=09=09=
=09=09=09=09=09=09=09=09=09<tr><td style=3D"padding:0px;"> =09=09=09=09=09=
=09=09=09=09=09=09=09=09<table cellspacing=3D"0" cellpadding=3D"0" border=
=3D"0" width=3D"100%" style=3D"border:0;border-spacing:0;border-collapse:co=
llapse;"> =09=09=09=09=09=09=09=09=09=09=09=09=09=09<tr><td style=3D"backgr=
ound:#fffcff; border:1px solid #f0d3ba; padding:16px;"> =09=09=09=09=09=09=
=09=09=09=09=09=09=09=09=09<table cellspacing=3D"0" cellpadding=3D"0" borde=
r=3D"0" width=3D"100%" style=3D"border:0;border-spacing:0;border-collapse:c=
ollapse;"> =09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09<tr><td style=3D=
"padding:6px 0px 6px 0px;">=09 =09=09=09=09=09=09=09=09=09=09=09=09=09=09=
=09=09=09<table cellspacing=3D"0" cellpadding=3D"0" border=3D"0" width=3D"1=
00%" style=3D"border:0;border-spacing:0;border-collapse:collapse;"> =09=09=
=09=09=09=09=09=09=09=09=09=09=09=09=09<tr><td style=3D"padding-bottom:0px;=
font-family: Tahoma, Arial, Helvetica, sans-serif; font-size: 14px; line-he=
ight: 24px; text-align: left;">We believe that the Editorial Board/Reviewer=
Team plays a significant role in taking the journal forward. Presented bel=
ow are several of the Editorial Members and Reviewers of <i>Chemical and Bi=
omolecular Engineering</i>.</td></tr> =09=09=09=09=09=09=09=09=09=09=09=09=
=09=09=09<tr><td style=3D" padding:0px;"> =09=09=09=09=09=09=09=09=09=09=09=
=09=09=09=09=09<table cellspacing=3D"0" cellpadding=3D"0" border=3D"0" widt=
h=3D"100%" style=3D"border:0;border-spacing:0;border-collapse:collapse;"> =
=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09<tr><td style=3D"padding=
:16px 0px; border-radius:6px;"> =09=09=09=09=09=09=09=09=09=09=09=09=09=09=
=09=09=09=09<table cellspacing=3D"0" cellpadding=3D"0" border=3D"0" width=
=3D"100%" style=3D"border:0;border-spacing:0;border-collapse:collapse;"> =
=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09<tr><td style=3D"t=
ext-align: left; padding-left:0px;"> =09=09=09=09=09=09=09=09=09=09=09=09=
=09=09=09=09=09=09=09=09<table cellspacing=3D"0" cellpadding=3D"0" border=
=3D"0" width=3D"100%" style=3D"border:0;border-spacing:0;border-collapse:co=
llapse;"> =09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09<tr><=
td><span style=3D"width: 40px; height: 3px; background: #979d9b; display:in=
line-block;"></span></td></tr> =09=09=09=09=09=09=09=09=09=09=09=09=09=09=
=09=09=09=09=09=09<tr><td style=3D"height:1px; background:#c3cbc9;font-size=
:0;"> </td></tr> =09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=
=09=09=09</table> =09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=
</td></tr> =09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09<tr><td=
style=3D"padding-top:0px; padding-bottom:6px;"> =09=09=09=09=09=09=09=09=
=09=09=09=09=09=09=09=09=09=09=09=09<table cellspacing=3D"0" cellpadding=3D=
"0" border=3D"0" width=3D"100%" style=3D"border:0;border-spacing:0;border-c=
ollapse:collapse;"> =09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=
=09=09<tr><td style=3D"font-family: Tahoma, Arial, Helvetica, sans-serif; f=
ont-size: 14px; line-height: 24px; text-align: left;"><span style=3D"color:=
#b5590a;">Muhammad Altaf Nazir</span><br/>Institute of Chemistry, The Islam=
ia University of Bahawalpur, Bahawalpur, Pakistan</td></tr> =09=09=09=09=09=
=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09</table> =09=09=09=09=09=09=09=
=09=09=09=09=09=09=09=09=09=09=09=09</td></tr> =09=09=09=09=09=09=09=09=09=
=09=09=09=09=09=09=09=09=09=09<tr><td style=3D"padding-bottom:6px;"> =09=09=
=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09<table cellspacing=3D"0"=
cellpadding=3D"0" border=3D"0" width=3D"100%" style=3D"border:0;border-spa=
cing:0;border-collapse:collapse;"> =09=09=09=09=09=09=09=09=09=09=09=09=09=
=09=09=09=09=09=09<tr><td style=3D"font-family: Tahoma, Arial, Helvetica, s=
ans-serif; font-size: 14px; line-height: 24px; text-align: left;"><span sty=
le=3D"color:#b5590a;">Dr. Arome Odiba</span><br/>Department of Genetics and=
Biotechnology, University of Nigeria, Nsukka, Nigeria</td></tr> =09=09=09=
=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09</table> =09=09=09=09=09=09=
=09=09=09=09=09=09=09=09=09=09=09=09</td></tr> =09=09=09=09=09=09=09=09=09=
=09=09=09=09=09=09=09=09=09=09<tr><td style=3D"padding-bottom:6px;"> =09=09=
=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09<table cellspacing=3D=
"0" cellpadding=3D"0" border=3D"0" width=3D"100%" style=3D"border:0;border-=
spacing:0;border-collapse:collapse;"> =09=09=09=09=09=09=09=09=09=09=09=09=
=09=09=09=09=09=09=09=09<tr><td style=3D"font-family: Tahoma, Arial, Helvet=
ica, sans-serif; font-size: 14px; line-height: 24px; text-align: left;"><sp=
an style=3D"color:#b5590a;">Dr. Udit Gupta</span><br/>Department of Chemica=
ls, Siemens Digital Industries Software, Parsippany, United States</td></tr=
> =09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09</table> =09=
=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09</td></tr> =09=09=09=
=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09<tr><td style=3D"padding-bo=
ttom:6px;"> =09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09<table=
cellspacing=3D"0" cellpadding=3D"0" border=3D"0" width=3D"100%" style=3D"b=
order:0;border-spacing:0;border-collapse:collapse;"> =09=09=09=09=09=09=09=
=09=09=09=09=09=09=09=09=09=09=09=09<tr><td style=3D"font-family: Tahoma, A=
rial, Helvetica, sans-serif; font-size: 14px; line-height: 24px; text-align=
: left;"><span style=3D"color:#b5590a;">Dr. Sameh Osman</span><br/>Departme=
nt of Chemistry, King Saud University, Riyadh, Saudi Arabia</td></tr> =09=
=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09</table> =09=09=09=09=
=09=09=09=09=09=09=09=09=09=09=09=09=09=09</td></tr> =09=09=09=09=09=09=09=
=09=09=09=09=09=09=09=09=09=09=09=09<tr><td style=3D" padding:0px;">...</td=
></tr> =09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09</table> =09=
=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09=09</td></tr> =09=09=09=09=09=
=09=09=09=09=09=09=09=09=09=09=09</table> =09=09=09=09=09=09=09=09=09=09=09=
=09=09=09=09</td></tr> =09=09=09=09=09=09=09=09=09=09=09=09=09=09=09<tr><td=
style=3D"padding:0px; border-radius:6px;"><table cellspacing=3D"0" cellpad=
ding=3D"0" border=3D"0" width=3D"100%" style=3D"border:0;border-spacing:0;b=
order-collapse:collapse;">=09<tr><td style=3D"font-family: Tahoma, Arial, H=
elvetica, sans-serif; font-size: 14px;color:#282828; line-height: 24px; tex=
t-align: justify;font-weight:bold;">Duties of the Reviewer or Editorial Mem=
ber involve:</td></tr>=09<tr><td style=3D"height:5px;line-height:5px;font-s=
ize:0;"> </td></tr>=09<tr><td style=3D"padding:0;font-family: Tahoma, =
Arial, Helvetica, sans-serif; font-size: 14px;color:#282828; line-height: 2=
4px; text-align: justify;">=09=09<ol style=3D"list-style-type:upper-alpha;m=
argin:0;padding:0 0 0 17px;">=09=09=09<li>Review two or three papers annual=
ly.</li>=09=09=09<li>Return review forms within given time (2 or 3 weeks).<=
/li>=09=09=09<li>Provide completed and detailed suggestions on submitted ma=
nuscripts.</li>=09=09=09<li>Serve for three years and may be reappointed fo=
r consecutive terms.</li>=09=09</ol>=09</td></tr></table></td></tr> =09=09=
=09=09=09=09=09=09=09=09=09=09=09=09</table> =09=09=09=09=09=09=09=09=09=09=
=09=09=09=09=09=09</td></tr> =09=09=09=09=09=09=09=09=09=09=09=09=09=09=09<=
/table> =09=09=09=09=09=09=09=09=09=09=09=09=09=09</td></tr> =09=09=09=09=
=09=09=09=09=09=09=09=09=09</table> =09=09=09=09=09=09=09=09=09=09=09=09</t=
d></tr> =09=09=09=09=09=09=09=09=09=09=09=09</table> =09=09=09=09=09=09=09=
=09=09=09=09</td></tr>=09 =09=09=09=09=09=09=09=09=09=09=09<tr><td style=3D=
"padding:20px; background:#fffcff;font-family: Tahoma, Arial, Helvetica, sa=
ns-serif; font-size: 14px; line-height: 24px; text-align: left;"><span styl=
e=3D"font-family: Tahoma, Arial, Helvetica, sans-serif; font-size: 14px; li=
ne-height: 24px; text-align: justify;">Abstract of the previous published a=
rticle (<span style=3D"font-style:italic;">Alzheimerova bolest - izazov dan=
a=C5=A1njice</span>): Alzheimerova bolest (AB) danas, kao jedna od tipi=C4=
=8Dnih i =C4=8Destih bolesti III. =C5=BEivotne dobi, a u kontekstu kada udi=
o starijih osoba u populaciji konstantno raste, dobiva sve vi=C5=A1e na zna=
=C4=8Denju. Kao i u drugim slu=C4=8Dajevima, kada je podignuta dru=C5=A1tve=
na svjesnost o bolesti, o potrebi =C5=A1to ranijeg dijagnosticiranja i lije=
=C4=8Denja, neminovno dolazimo do situacije kada oboljeli, a onda i njihove=
obitelji, sve dulje vremena =C5=BEive s dijagnozom AB. Tu, svakako optere=
=C4=87uju=C4=87u poziciju moramo amortizirati putem sustavnog i svekolikog =
post-dijagnosti=C4=8Dkog suporta, koji treba biti individualno skrojen, uva=
=C5=BEavaju=C4=87i sve specifi=C4=8Dne afinitete pojedinca s jedne strane, =
te preostale osobne mogu=C4=87nosti (koje zavise od stupnja te=C5=BEine bol=
esti) s druge strane. Multidisciplinarni pristup podr=C5=A1ke usmjeren prem=
a osobi i njegovatelju klju=C4=8D je kvalitetne skrbi za osobe s neurokogni=
tivnim poreme=C4=87ajima. Pred dana=C5=A1njim znanstvenicima stoji (te=C5=
=BEak) zadatak detekcije AB u fazi prije pojave klini=C4=8Dkih simptoma, i =
to putem pouzdane, neinvazivne, lako primjenljive i jeftine metode. Nakon t=
akvog budu=C4=87eg testiranja osoba s pove=C4=87anim rizikom ili =C4=8Dak m=
o=C5=BEda i skrininga populacije, biti =C4=87e potrebno u pozitivnih osoba =
primijeniti inovativnu terapiju koja =C4=87e imati mogu=C4=87nost modificir=
anja prirodnog tijeka bolesti, na na=C4=8Din da ga odgodi (za makar 5 godin=
a), =C5=A1to bi omogu=C4=87ilo ve=C4=87ini oboljelih da tijekom =C5=BEivota=
ne razviju te=C5=BEu, onesposobljavaju=C4=87u klini=C4=8Dku sliku demencij=
e. Naime, u dana=C5=A1nje doba, kada mnoge starije osobe =C5=BEive same, vr=
lo je va=C5=BEno stvoriti uvjete koji bi im omogu=C4=87ili =C5=A1to dulje f=
unkcioniranje bez ili samo s manjom tu=C4=91om pomo=C4=87i. U tome =C4=87e =
sve vi=C5=A1e i vi=C5=A1e imati udjela i napredna asistivna tehnologija koj=
a =C4=87e putem raznih aplikacija, tehnolo=C5=A1kih pomagala, pa i robota, =
pomagati starijim osobama. Trebati =C4=87e jo=C5=A1 neko (kra=C4=87e) vrije=
me dok se ne prona=C4=91u u=C4=8Dinkovitiji lijekovi od postoje=C4=87ih, na=
tome se intenzivno radi, testiraju se razli=C4=8Dite supstance i pristupi,=
na pr. lijekovi koji djeluju na tau-protein, imunoterapija, infuzije, vakc=
ine. Upravo zbog toga =C5=A1to se u slu=C4=8Daju AB i drugih demencija radi=
o javnozdravstvenom prioritetu potrebno je, radi najbolje skrbi za osobe s=
demencijom, imati nacionalnu strategiju koja =C4=87e definirati klju=C4=8D=
ne ciljeve, standardne postupke i trenutne prioritete. Takav pristup pomo=
=C4=87i =C4=87e oboljelima, njihovim bli=C5=BEnjima a onda i cijelom dru=C5=
=A1tvu.<span></td></tr> =09=09=09=09=09=09=09=09=09=09</table> =09=09=09=09=
=09=09=09=09=09</td></tr> =09=09=09=09=09=09=09=09</table> =09=09=09=09=09=
=09=09</td></tr> =09=09=09=09=09=09</table> =09=09=09=09=09</td></tr> =09=
=09=09=09</table> =09=09=09<tr><td style=3D"font-size: 14px;text-align:cent=
er;padding: 20px 0;line-height:18px;font-family:Tahoma, Arial, Helvetica, s=
ans-serif;color: #222222;">Want to stop the email service? <a href=3D"http:=
//www.chembiomoleng.com/us/wsabxr" border=3D"0" target=3D"_blank" style=3D"=
display:inline-block;background:#FFC107;padding:2px 6px;border-radius:6px;t=
ext-decoration:none;color:#121212;white-space:nowrap;font-size:15px;line-he=
ight:18px;">Unsubscribe</a></td></tr></td></tr></table></td></tr></table> <=
/body> </html>=20